Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

UCSF Receives $2 Million to Advance UC-Wide Biobanking Initiative

Published: Thursday, November 15, 2012
Last Updated: Thursday, November 15, 2012
Bookmark and Share
Goal of the project is to develop an ethical, efficient and sustainable system for obtaining, processing and sharing biospecimens and data.

UCSF's Clinical and Translational Science Institute (CTSI) has been awarded $2 million to advance a biobanking project involving the five University of California campuses.

The goal of the project, Engaging University of California Stakeholders for Biorepository Research (EngageUC), is to develop an ethical, efficient and sustainable system for obtaining, processing and sharing biospecimens and data.

It includes outpatient facilities at the UC medical center campuses - Davis, Irvine, Los Angeles, San Diego and San Francisco.

This award by the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH), is a supplement to the five-year, $112 million renewal award (grant number UL1 TR000004) that UCSF’s CTSI received as part of the Clinical and Translational Science Award program in 2011.

“This is a very important project,” said Clay Johnston, MD, PhD, associate vice chancellor of research and director of CTSI at UCSF.

Johnston continued, “Not only does it deal with a critical issue about appropriate consent for biospecimens, a problem we’re much better able to address together, but it also builds on relationships across the UCs that we’ve been bridging more and more successfully recently through efforts such as UC BRAID.”

Johnston is also co-principal investigator with Steven Dubinett, MD, associate vice chancellor for research and director of the Clinical and Translational Science Institute at UCLA.

The three-year project includes four main components:

• Facilitating coordination among UC institutional officials and Institutional Review Boards (IRBs);
• Developing harmonized procedures among UC biorepository researchers and leaders;
• Undertaking a randomized control trial to determine optimal methods for obtaining informed consent from patients; and
• Educating California's diverse communities to provide engaged input and feedback on UC's biorepository studies.

EngageUC is co-directed by Elizabeth Boyd, PhD, associate vice chancellor of Ethics and Compliance, program director of CTSI’s Regulatory Knowledge and Support Program and associate adjunct professor of Social and Behavioral Science at UCSF; Sarah Dry, MD, associate professor in the UCLA David Geffen School of Medicine; and Daniel Dohan, PhD, associate professor of Health Policy and Social Medicine and associate director of the Philip R. Lee Institute for Health Policy Studies at UCSF.

John Wilbanks, an expert on portable legal consent issues, is serving as a consultant on the project.

“This research will address one of the most pressing challenges facing bioethics - how best to inform participants about the research that may be conducted with their donated, discarded tissue,” Boyd said. “It will also allow us to develop best practices for the University of California.”

According to Dohan, EngageUC is particularly exciting because it is bringing together stakeholders - from researchers and leaders at UC to a diverse group of Californians from across the state - to determine how biobanking can be an effective tool for improving health.

EngageUC is also being informed by the Biobanking Initiative of UC BRAID, an existing consortium of the UC medical campuses focused on advancing clinical and translational research.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More Than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Wednesday, February 03, 2016
MedImmune, UCSF Launch Collaboration
Top scientists partner to research the progression and biology of RIA diseases.
Thursday, January 14, 2016
Agricultural Intervention Improves HIV Outcomes
A multifaceted farming intervention can reduce food insecurity while improving HIV outcomes in patients in Kenya, according to a randomized, controlled trial led by researchers at UC San Francisco.
Thursday, August 20, 2015
How Early Childhood Vaccination Reduces Leukemia Risk
Chronic infections push ‘pre-leukemia’ cells, common in newborns, into malignancy.
Thursday, May 21, 2015
Blood Test Trumps Accuracy of Standard Screening in Detecting Down Syndrome in Early Pregnancy
A blood test undertaken between 10 to 14 weeks of pregnancy may be more effective in diagnosing Down syndrome and two other less common chromosomal abnormalities than standard non-invasive screening techniques.
Thursday, April 02, 2015
Developing a Noninvasive Test for Endometriosis
UCSF researchers identify patterns of genetic activity that could help in early detection of disorder.
Monday, November 24, 2014
Environmental Carcinogens Leave Distinctive Genetic Imprints in Tumors
Chemically induced tumors bear ‘smoking gun’ traces that sharply differentiate them from genetically engineered cancers.
Thursday, November 06, 2014
Human Cancer Prognosis Is Related to Newly Identified Immune Cell
A rare population of tumor-associated “good” cells slows cancer.
Monday, October 20, 2014
Chromosome Therapy to Correct a Severe Chromosome Defect
Induced pluripotent stem cell reprogramming offers potential to correct abnormal chromosomes.
Tuesday, January 14, 2014
Type 1 Diabetes Drug Proves Effective in Clinical Trial
Drug developed by UCSF researcher shows promise for blocking advance of disease in earliest stages.
Thursday, August 08, 2013
Supreme Court Rules That Human Genes Can’t Be Patented
Most agree that the ruling reduces barriers to genetic testing and enables scientists to further genetic research and share data aimed ultimately at preventing and curing disease.
Friday, June 14, 2013
UCSF Medical Center Publishes First Sustainability Report
Report documents a variety of initiatives underway for constructing green buildings, conserving energy and water, offering sustainable food and creating systems to divert waste.
Friday, April 12, 2013
HIV Testing Increased and Infection Reduced in Africa with Community Intervention
Free mobile HIV testing and counseling, same-day results and post-test support reduces HIV infections by 14 percent.
Thursday, March 07, 2013
Stem Cell Survival Strategy Is Key to Blood and Immune System Health
Stem cells of the aging bone marrow recycle their own molecules to survive and keep replenishing the blood and immune systems as the body ages.
Monday, February 18, 2013
Scientists Identify Key Biological Mechanism in Multiple Sclerosis
Imaging study finds potential new target to combat disease.
Tuesday, December 04, 2012
Scientific News
Head Injury Patients have Protein Clumps Associated with Alzheimer’s Disease
Scientists have revealed that protein clumps associated with Alzheimer's disease are also found in the brains of people who have had a head injury.
Exposure to Air Pollution 30 Years Ago Associated with Increased Risk of Death
Exposure to air pollution more than 30 years ago may still affect an individual's mortality risk today, according to new research from Imperial College London.
More Then 1 in 20 U.S. Children have Dizziness and Balance Problems
Researchers at NIH have found that girls have a higher prevalence of dizziness and balance problems compared to boys, 5.7 percent and 5.0 percent.
Biosensors on Demand
New strategy results in custom "designer proteins" for sensing a variety of molecules.
Low-Cost, Portable NQR Spectroscopy
A researcher at Case Western Reserve University is developing a low-cost, portable prototype designed to detect tainted medicines and food supplements that otherwise can make their way to consumers. The technology can authenticate good medicines and supplements.
Structure of Brain Plaques in Huntington's
Researchers at the University of Pittsburgh School of Medicine have shown that the core of the protein clumps found in the brains of people with Huntington's disease have a distinctive structure, a finding that could shed light on the molecular mechanisms underlying the neurodegenerative disorder.
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Unique Mechanism for a High-Risk Leukemia
Researchers uncovered the aberrant mechanism underlying a notoriously treatment-resistant acute lymphoblastic leukemia subtype; findings offer lessons for understanding all cancers.
Visualizing a Cancer Drug Target at Atomic Resolution
Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!